Transcatheter aortic valve implantation (TAVI) is an appropriate therapy to treat elderly patients with severe aortic stenosis considered high-risk surgical candidates. The safety and effectiveness of TAVI have been demonstrated in numerous observational clinical studies, national registries and also in controlled randomized trial [1,2].
The less invasive approach should be considered the transfemoral one, nevertheless a number of patients that are referred for TAVI are not eligible for trans-femoral access due to calcification, vascular narrowing, or tortuosity of ileo-femoral arteries. For them, the transapical, subclavian, or direct aortic approaches may be a suitable alternative. The choice of alternative access should be determined by the heart team based on anatomic characteristics and clinical status of the patient.
We report the case of a 75-year-old female affected by Leriche syndrome who successfully underwent valve-in-surgical valve TAVI, through a direct aortic approach, with a Medtronic CoreValve Evolut R.
Published on: Sep 28, 2016 Pages: 38-40
Huazong University of Science and Technology, China
Peertechz Journal of Pediatric Therapy
William CS Cho
Queen Elizabeth Hospital, Hong Kong
International Journal of Immunotherapy and Cancer Research
Beijing University of Technology , PR China
Journal of Civil Engineering and Environmental Sciences
Catholic University of Rome, Italy
Peertechz Journal of Orthopedics and Rheumatology
Leeds Beckett University, UK
Archives of Community Medicine and Public Health